News

benzinga_article
2025.11.03 19:49
Regencell Bioscience shares are trading lower after the company received a subpoena indicating the DOJ is conducting an investigation into the trading in its Ordinary Shares. Additionally, the company said there is substantial doubt about its ability to continue as a going concern.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.